Gregory Korbel
Geschäftsführer bei Atrin Pharmaceuticals, Inc.
Vermögen: 5 741 $ am 30.04.2024
Aktive Positionen von Gregory Korbel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Geschäftsführer | - | - |
Karriereverlauf von Gregory Korbel
Ehemalige bekannte Positionen von Gregory Korbel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
APREA THERAPEUTICS, INC. | Geschäftsführer | 01.05.2022 | 31.03.2023 |
Corporate Officer/Principal | 01.07.2016 | 01.05.2022 | |
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Geschäftsführer | 01.08.2012 | 01.12.2015 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Ausbildung von Gregory Korbel
Vanderbilt University | Undergraduate Degree |
Harvard University | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Chief Operating Officer | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
APREA THERAPEUTICS, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 2 |
---|---|
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Health Technology |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Health Technology |
- Börse
- Insiders
- Gregory Korbel
- Erfahrung